3 Blue-Chip Stocks Too Expensive to Consider Now

Income investors are often advised to find dividend-paying blue-chip stocks, but make sure you're not just getting a good stock, but a good price. More 

2 Drug Stocks To Buy For Safe Dividends And 20% Gains

With all the talk on the campaign trail about drug costs, it's safe to say the pharmaceutical industry is under siege. But these drug stocks are solid buys More 

10 Blue-Chip Stocks You Don’t Need Anymore

These 10 blue-chip stocks are trading more on reputation than actual future potential. It might be painful, but it's time to cut the cord. More 

64 Actions to Take on Monday’s Market Dip

It pays to stay on top of the latest profit opportunities, and today's blog post is a great place to start after Monday's route More 

Merck (MRK) Stock: Q4 Earnings Highlights

Merck released its earnings report for the fourth quarter of 2015 and it also included guidance for the full year of 2016 with it. More 

4 Healthcare Stocks on Shaky Ground – MRK LLY AZN BMY

Biotechnology stocks have broken down, and certain pharmaceutical stocks are now following suit. Could Merck and other pharmas suffer more downside? More 

FDA Approves Merck Hepatitis C Drug

Merck has been given approval by the U.S. Food and Drug Administration for its Hepatitis C drug Zepatier for genotype 1 and 4 infections. More